FDA issued a Warning Letter to Divi's Laboratories Ltd. (Unit II) on 4/13/2017 for a later inspection.
483 Divi's Labs (Unit II) Jul 2012

483 Divi's Labs (Unit II) Jul 2012

Daniel Roberts FDA$119.00 - Available Now

FDA investigators audited the Divi's Labs (Unit II) - Visakhapatnam District, India facility and issued inspectional observations (via FDA 483) on 19 Jul 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Jul 2012
  • Location: Visakhapatnam District, India
  • FEI: 3004149463
Add To Cart